
"I am glad that taking part in a trial might help others on their own cancer journey.”
This trial tried to find out if chemotherapy followed by chemotherapy and radiotherapy together improved treatment for women with locally advanced cancer of the cervix (cervical cancer).
If it can’t be removed with surgery, doctors usually treat cervical cancer with chemotherapy and radiotherapy at the same time. This is called chemoradiation.
Early research had shown that giving chemotherapy on its own before chemoradiation may be helpful. But doctors weren’t sure how well this would work. All treatments have side effects and it is important that people don’t have extra treatments they don’t need.
In this trial, women with locally advanced cervical cancer had chemotherapy followed by chemoradiation. The aim of the trial was to find out if the extra chemotherapy was useful. And to find out more about the side effects of this new combination of treatment.
The trial team found that having chemotherapy before chemoradiation was possible and useful for women with locally advanced cervical cancer.
This was a phase 2 trial. It recruited 46 women with locally advanced cervical cancer. Everyone had paclitaxel and carboplatin chemotherapy before having cisplatin and radiotherapy (chemoradiation).
The trial team were able to look at how well cervical cancer responded to initial chemotherapy in 44 women. They found that
3 months after completing all their treatment (chemotherapy and chemoradiation), the trial team were able to look at how well the cervical cancer had responded in 43 women. They found that
At 3 and 5 years after treatment, the trial team found that about 7 out of every 10 women (70%) were still alive and free of cancer.
Overall the worst side effect from treatment was a drop in blood cells causing an increased risk of infection, bruising and bleeding. Other side effects reported included feeling and being sick, diarrhoea and constipation.
The trial team concluded that treating cervical cancer with chemotherapy followed by chemoradiation was possible and useful. They have used the results of this trial to design a bigger, international phase 3 trial to find out how useful this combination of treatment is for cervical cancer.
We have based this summary on information from the team who ran the trial. The information they sent us has been reviewed by independent specialists () and published in a medical journal. The figures we quote above were provided by the trial team. We have not analysed the data ourselves.
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Mary McCormack
Bristol-Myers Squibb
Cancer Research UK & UCL Cancer Trials Centre
NIHR Clinical Research Network: Cancer
NIHR University College London Hospitals Biomedical Research Centre
University College London (UCL)
Freephone 0808 800 4040
"I am glad that taking part in a trial might help others on their own cancer journey.”